GSK-1292263
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- GSK-1292263
- DrugBank Accession Number
- DB12627
- Background
GSK1292263 has been investigated for the treatment of DIABETES MELLITUS, TYPE 2.
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 456.56
Monoisotopic: 456.183126572 - Chemical Formula
- C23H28N4O4S
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as phenylpyridines. These are polycyclic aromatic compounds containing a benzene ring linked to a pyridine ring through a CC or CN bond.
- Kingdom
- Organic compounds
- Super Class
- Organoheterocyclic compounds
- Class
- Pyridines and derivatives
- Sub Class
- Phenylpyridines
- Direct Parent
- Phenylpyridines
- Alternative Parents
- Benzenesulfonyl compounds / Dialkylarylamines / Alkyl aryl ethers / Piperidines / Sulfones / Heteroaromatic compounds / 1,2,4-oxadiazoles / Oxacyclic compounds / Azacyclic compounds / Organic oxides show 1 more
- Substituents
- 1,2,4-oxadiazole / 2-phenylpyridine / Alkyl aryl ether / Amine / Aromatic heteromonocyclic compound / Azacycle / Azole / Benzenesulfonyl group / Benzenoid / Dialkylarylamine show 15 more
- Molecular Framework
- Aromatic heteromonocyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- R1J57STA6O
- CAS number
- 1032823-75-8
- InChI Key
- AYJRTVVIBJSSKN-UHFFFAOYSA-N
- InChI
- InChI=1S/C23H28N4O4S/c1-16(2)22-25-23(31-26-22)27-12-10-17(11-13-27)15-30-19-6-9-21(24-14-19)18-4-7-20(8-5-18)32(3,28)29/h4-9,14,16-17H,10-13,15H2,1-3H3
- IUPAC Name
- 2-(4-methanesulfonylphenyl)-5-({1-[3-(propan-2-yl)-1,2,4-oxadiazol-5-yl]piperidin-4-yl}methoxy)pyridine
- SMILES
- CC(C)C1=NOC(=N1)N1CCC(COC2=CC=C(N=C2)C2=CC=C(C=C2)S(C)(=O)=O)CC1
References
- General References
- Not Available
- External Links
- PubChem Compound
- 24996872
- PubChem Substance
- 347828838
- ChemSpider
- 25027409
- ChEMBL
- CHEMBL3187503
- ZINC
- ZINC000068208690
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.0679 mg/mL ALOGPS logP 4.02 ALOGPS logP 4.11 Chemaxon logS -3.8 ALOGPS pKa (Strongest Acidic) 19.69 Chemaxon pKa (Strongest Basic) 3.71 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 7 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 98.42 Å2 Chemaxon Rotatable Bond Count 7 Chemaxon Refractivity 123.81 m3·mol-1 Chemaxon Polarizability 50.72 Å3 Chemaxon Number of Rings 4 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-0a4i-0000900000-b3dd10ba64912c80ad1d Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-0a4i-0000900000-056d97497dec6d3942ae Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-0a6r-0025900000-460194652a62aac61d1a Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-0abi-1019700000-af8a764632d9846e4699 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-07vi-2796400000-321fcd5fd0e1ff8c9c61 Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-004i-8439600000-6138921601d17ab14c4a Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 215.70465 predictedDeepCCS 1.0 (2019) [M+H]+ 218.06264 predictedDeepCCS 1.0 (2019) [M+Na]+ 224.25659 predictedDeepCCS 1.0 (2019)
Drug created at October 20, 2016 23:19 / Updated at June 12, 2020 16:53